ESC 365 - New role of EPAC1 in Anthracycline-induced cardiotoxicity and anticancer therapy

ESC Premium Access

New role of EPAC1 in Anthracycline-induced cardiotoxicity and anticancer therapy

Session: Cardio-Oncology: insights from basic , clinical, data science

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Miss A. BELHADEF (Chatenay-Malabry, FR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Miss Anissa BELHADEF

University of Paris-Sud 11 UMR-S 1180, Chatenay-Malabry (France)

0 follower

6 more presentations in this session

Effect of calcitriol attenuates doxorubicin-induced cardiac dysfunction in mice model: focus on endothelial-to-mesenchymal transition

Speaker: Doctor T. Tsai (Kaohsiung, TW)

Usefulness of cardiac magnetic resonance imaging for early detection of subclinical chemotherapy-related cardiac dysfunction in cancer patients

Speaker: Doctor Y. Terui (Sendai, JP)

CMR Fast-SENC intramyocardial LV & RV segmental strain detects cardiotoxicity during oncology treatment and impact of cardioprotection therapy before echocardiography

Speaker: Doctor M. Montenbruck (Hamburg, DE)

Malignancy after Heart Transplantation: Difference in incidence and prognosis between genders. Data from the Spanish post-Heart Transplant Tumor Registry.

Speaker: Doctor C. Minguito Carazo (A Coruna, ES)

Prevention of heart failure in treatments with trastuzumab and anthracyclines: a meta-analysis

Speaker: Professor F. Braunschweig (Stockholm, SE)

Access the full session

Cardio-Oncology: insights from basic , clinical, data science

Speakers: Miss A. BELHADEF, Doctor T. Tsai, Doctor Y. Terui, Doctor M. Montenbruck, Doctor C. Minguito Carazo...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources